Q 32 Bio Inc stock is traded at $9.17, with a volume of 17,829. It is up +3.62% in the last 24 hours and up +13.07% over the past month. Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).
Previous Close:
$8.85
Open:
$8.83
24h Volume:
17,829
Relative Volume:
0.05
Market Cap:
$274.40M
Revenue:
$53.74M
Net Income/Loss:
$33.24M
P/E Ratio:
3.44
EPS:
$2.66
Net Cash Flow:
-$27.40M
1W Performance:
+2.92%
1M Performance:
+13.07%
6M Performance:
+67.64%
1Y Performance:
+295.26%
1-Day Range:
$8.83$9.17
1-Week Range:
$8.23$9.17
52-Week Range:
$1.91$23.57
Q 32 Bio Inc Stock (QTTB) Company Profile
Name
Q 32 Bio IncSector
HealthcareIndustry
BiotechnologyPhone
781-999-0232Address
830 WINTER STREET, WALTHAM, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS